ArticleCancer prevention research (Philadelphia, Pa.)2020
Disparities in Cancer Prevention in the COVID-19 Era.
Article in Cancer prevention research (Philadelphia, Pa.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.
- Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.Journal of gastrointestinal cancer · 2022Pooled it
- Long-Term Health and Economic Impacts of COVID-19 Disruptions on Bowel Cancer Inequalities in Victoria, Australia: A Modelling Study.Cancer medicine · 2026Article
- Early and late-onset colorectal cancer in African Americans during COVID-19.World journal of gastrointestinal oncology · 2025Article
- Impact of the COVID-19 pandemic on lung cancer screening utilization and outcome: a health examination center retrospective study.Annals of medicine · 2025Article
- Beliefs about the effects of health behaviors on cancer risk: findings from the 2022 Health Information National Trends Survey.Cancer causes & control : CCC · 2025Article
- Cancer Screening Progress and Noninvasive Screening Opportunities since the Onset of the COVID-19 Pandemic.Cancer prevention research (Philadelphia, Pa.) · 2025Article
- Evaluation of performance indicators of a national breast cancer screening program in Casablanca, Morocco.BMC cancer · 2025Article
- Cancer-related health behaviors during the COVID 19 pandemic in geographically diverse samples across the US.BMC cancer · 2025Article
- Article
- Changes in Urologic Cancer Surgical Volume and Length of Stay During the COVID-19 Pandemic in Pennsylvania.JAMA network open · 2023Article
- Inequalities in colorectal cancer screening uptake in Wales: an examination of the impact of the temporary suspension of the screening programme during the COVID-19 pandemic.BMC public health · 2023Article
- Socioeconomic disparities in colorectal cancer survival: contributions of prognostic factors in a large Australian cohort.Journal of cancer research and clinical oncology · 2022Article
- Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy.Cancer prevention research (Philadelphia, Pa.) · 2022Article
- Differences in Cancer Screening Responses to State Medicaid Expansions by Race and Ethnicity, 2011‒2019.American journal of public health · 2022Article
- Medical avoidance among marginalized groups: the impact of the COVID-19 pandemic.Journal of behavioral medicine · 2022Article
- Impact of the COVID-19 breast cancer screening hiatus on clinical stage and racial disparities in New York City.American journal of surgery · 2022Article
- Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2022Article
- Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population.Gastroenterology · 2022Article
- Low Rates of Lung and Colorectal Cancer Screening Uptake Among a Safety-net Emergency Department Population.The western journal of emergency medicine · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 1 country.
Funding
Abstract
Screening for cancer is a proven and recommended approach to prevent deaths from cancer; screening can locate precursor lesions and/or cancer at early stages when it is potentially curable. Racial and ethnic minorities and other medically underserved populations exhibit lower uptake of cancer screening than nonminorities in the United States. The COVID-19 pandemic, which disproportionately affected minority communities, has curtailed preventive services including cancer screening to preserve personal protective equipment and prevent spread of infection. While there is evidence for a rebound from the pandemic-driven reduction in cancer screening nationally, the return may not be even across all populations, with minority population screening that was already behind becoming further behind as a result of the community ravages from COVID-19. Fear of contracting COVID-19, limited access to safety-net clinics, and personal factors like, financial, employment, and transportation issues are concerns that are intensified in medically underserved communities. Prolonged delays in cancer screening will increase cancer in the overall population from pre-COVID-19 trajectories, and elevate the cancer disparity in minority populations. Knowing the overall benefit of cancer screening versus the risk of acquiring COVID-19, utilizing at-home screening tests and keeping the COVID-19-induced delay in screening to a minimum might slow the growth of disparity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.